APA (7th ed.) Citation

Sachpekidis, C., Karampinis, I., Jakob, J., Kasper, B., Nowak, K., Pilz, L. R., . . . Ronellenfitsch, U. (2019). Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group. Cancers, 11(6), . https://doi.org/10.3390/cancers11060790

Chicago Style (17th ed.) Citation

Sachpekidis, Christos, et al. "Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group." Cancers 11, no. 6 (2019). https://doi.org/10.3390/cancers11060790.

MLA (9th ed.) Citation

Sachpekidis, Christos, et al. "Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic 18F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group." Cancers, vol. 11, no. 6, 2019, https://doi.org/10.3390/cancers11060790.